2025 Southeast CASC Regional Science Symposium

Overview

The 2025 Southeast CASC Regional Science Symposium will be held September 9-11, 2025, at the Renaissance Hotel in Downtown Asheville, NC.

The SE CASC regional science symposium supports climate adaptation efforts by sharing science resources and tools. The symposium will also offer resource managers and regional experts an opportunity to explore lessons learned and best practices.

There will be dedicated time to discuss and identify gaps and needs for actionable science production and delivery that meets the requirements of managers for on-the-ground application.

The symposium also serves as a platform for researchers, managers, students, and professionals to exchange information about their current activities, plans, and potential opportunities for collaboration.

September 9, 2025 8:00am - September 11, 2025 5:00pm

Renaissance Hotel
31 Woodfin St
Asheville, NC 28801

See registration page for pricing information

Bioeconomy

June 4, 2026

AGRITX 'egg spray' technology brings new life to poultry health

If you ask Gina Sloan, Ph.D., the age-old question about which comes first, the chicken or the egg, she’ll have a quick answer: both.

That’s because she’s a poultry pioneer, who is co-founder and CEO of a Statesville company with a unique system for spraying fertilized eggs with nutrients that give a health boost to the developing chicks inside.

January 22, 2026

Asheville healthcare startup working to reduce risks of falls in the home

As doctors and patients shift more care delivery to the home, it’s becoming more apparent that homes aren’t always the safest place to be.

December 6, 2024

Asheville’s Olfax Medical seeking to launch new migraine treatment

An Asheville specialty pharmaceutical company is working to transform a century-old medical procedure into a treatment for migraine relief that patients can easily perform at home.

Olfax Medical has developed a nasally administered drug delivery technology, potentially allowing patients to treat themselves easily anytime, wherever they are. The company is using its device to create novel therapeutics for a range of central nervous system disorders beyond migraine.